Literature DB >> 16436406

Tobacco industry litigation strategies to oppose tobacco control media campaigns.

J K Ibrahim1, Stanton A Glantz.   

Abstract

OBJECTIVE: To document the tobacco industry's litigation strategy to impede tobacco control media campaigns.
METHODS: Data were collected from news and reports, tobacco industry documents, and interviews with health advocates and media campaign staff.
RESULTS: RJ Reynolds and Lorillard attempted to halt California's Media Campaign alleging that the campaign polluted jury pools and violated First Amendment rights because they were compelled to pay for anti-industry ads. The American Legacy Foundation was accused of violating the Master Settlement Agreement's vilification clause because its ads attacked the tobacco industry. The tobacco companies lost these legal challenges.
CONCLUSION: The tobacco industry has expanded its efforts to oppose tobacco control media campaigns through litigation strategies. While litigation is a part of tobacco industry business, it imposes a financial burden and impediment to media campaigns' productivity. Tobacco control professionals need to anticipate these challenges and be prepared to defend against them.

Entities:  

Mesh:

Year:  2006        PMID: 16436406      PMCID: PMC2563618          DOI: 10.1136/tc.2005.014142

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  20 in total

1.  The Florida "truth" anti-tobacco media evaluation: design, first year results, and implications for planning future state media evaluations.

Authors:  D F Sly; G R Heald; S Ray
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

Review 2.  Reductions in smoking prevalence and cigarette consumption associated with mass-media campaigns.

Authors:  Karen Friend; David T Levy
Journal:  Health Educ Res       Date:  2002-02

3.  Getting to the truth: evaluating national tobacco countermarketing campaigns.

Authors:  Matthew C Farrelly; Cheryl G Healton; Kevin C Davis; Peter Messeri; James C Hersey; M Lyndon Haviland
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

4.  Failure to defend a successful state tobacco control program: policy lessons from Florida.

Authors:  M S Givel; S A Glantz
Journal:  Am J Public Health       Date:  2000-05       Impact factor: 9.308

5.  Tobacco control advocates must demand high-quality media campaigns: the California experience.

Authors:  E D Balbach; S A Glantz
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

6.  Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control.

Authors:  Anne Landman; Pamela M Ling; Stanton A Glantz
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

7.  Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

Authors:  C M Fichtenberg; S A Glantz
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

8.  Changes in youth cigarette use and intentions following implementation of a tobacco control program: findings from the Florida Youth Tobacco Survey, 1998-2000.

Authors:  U E Bauer; T M Johnson; R S Hopkins; R G Brooks
Journal:  JAMA       Date:  2000-08-09       Impact factor: 56.272

9.  Tobacco industry allegations of "illegal lobbying" and state tobacco control.

Authors:  S A Bialous; B J Fox; S A Glantz
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

10.  Evaluation of antismoking advertising campaigns.

Authors:  L K Goldman; S A Glantz
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

View more
  14 in total

1.  Turning negative into positive: public health mass media campaigns and negative advertising.

Authors:  D E Apollonio; R E Malone
Journal:  Health Educ Res       Date:  2008-10-23

2.  Global tobacco control and economic norms: an analysis of normative commitments in Kenya, Malawi and Zambia.

Authors:  Raphael Lencucha; Srikanth K Reddy; Ronald Labonte; Jeffrey Drope; Peter Magati; Fastone Goma; Richard Zulu; Donald Makoka
Journal:  Health Policy Plan       Date:  2018-04-01       Impact factor: 3.344

3.  Do we believe the tobacco industry lied to us? Association with smoking behavior in a military population.

Authors:  Robert C Klesges; Deborah A Sherrill-Mittleman; Margaret Debon; G Wayne Talcott; Robert J Vanecek
Journal:  Health Educ Res       Date:  2009-06-15

4.  Pushing secondhand smoke and the tobacco industry outside the social norm to reduce adolescent smoking.

Authors:  Anna V Song; Stanton A Glantz
Journal:  J Adolesc Health       Date:  2008-07-31       Impact factor: 5.012

5.  Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International.

Authors:  Eric Crosbie; Particia Sosa; Stanton A Glantz
Journal:  Tob Control       Date:  2017-03-23       Impact factor: 7.552

6.  Strong tobacco control program requirements and secure funding are not enough: lessons from Florida.

Authors:  Allison Kennedy; Sarah Sullivan; Yogi Hendlin; Richard Barnes; Stanton Glantz
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

Review 7.  Tobacco industry denormalisation as a tobacco control intervention: a review.

Authors:  Ruth E Malone; Quinn Grundy; Lisa A Bero
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

8.  Tobacco control law implementation in a middle-income country: Transnational tobacco control network overcoming tobacco industry opposition in Colombia.

Authors:  Randy Uang; Eric Crosbie; Stanton A Glantz
Journal:  Glob Public Health       Date:  2017-08-17

9.  Costa Rica's implementation of the Framework Convention on Tobacco Control: Overcoming decades of industry dominance.

Authors:  Eric Crosbie; Patricia Sosa; Stanton A Glantz
Journal:  Salud Publica Mex       Date:  2016 Jan-Feb

10.  The quarter that changed the world.

Authors:  April Roeseler; David Burns
Journal:  Tob Control       Date:  2010-04       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.